Earnings

bioAffinity Technologies Q3 EPS $(5.89) Up From $(71.05) YoY, Sales $1.070M Down From $1.446M YoY

Nov 6, 2026 · 05:43 PM ET· updated 53m ago

bioAffinity Technologies (NASDAQ:BIAF) reported quarterly losses of $(5.89) per share. This is a 91.71 percent increase over losses of $(71.05) per share from the same period last year. The company reported $1.070

Why It Matters

bioAffinity lost less money per share than last year, which is good. But sales went down, so watch if the company can grow revenue soon.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

BIAF2.52

-0.08 (-3.08%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.